Company / SG&A per Share
Aurinia Pharmaceuticals Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.72
FY2025
5-year range
$0.20 / $1.38
FY2021-FY2025
Trend
-39.6%
vs FY2024
Sector context
#144 of 210
Health Care
What the data says
At $0.72, Aurinia Pharmaceuticals Inc.'s sg&a per share ranks #67 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 8 years, ranging from $0.16 in FY2018 to $1.38 in FY2023.
Based on SEC 10-K filings.
0.72 in FY2025 with a 5-year CAGR of -8.7%.
Improved from $1.38 to $0.72 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -2.0%
- 5-Year CAGR
- -8.7%
- 10-Year CAGR
- -
Sector benchmark
#67 of 210 in Health CareTop 31% of 210This company $0.72 Sector average $29.50
▼
-97.6% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 39.6% year-over-year.
- Ranks #144 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.72 | -39.6% |
| FY2024 | $1.20 | -13.2% |
| FY2023 | $1.38 | +79.3% |
| FY2022 | $0.77 | +285.0% |
| FY2021 | $0.20 | -82.5% |
| FY2020 | $1.14 | +374.7% |
| FY2019 | $0.24 | +48.4% |
| FY2018 | $0.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026